AI assistant
Sending…
Amphastar Pharmaceuticals, Inc. — Director's Dealing 2016
Jun 14, 2016
10216_dirs_2016-06-13_adc4d6d7-ba5f-4af4-9db2-3ba4f1d5a8bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2016-06-09
Reporting Person: Shandell Jason B. (Director, President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-09 | Common Stock | S | 9904 | $16.43 | Disposed | 216610 | Direct |
Footnotes
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2015.
More from Amphastar Pharmaceuticals, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Investor Presentation
2026
Jun 3
Investor Presentation
2026
May 14
Interim / Quarterly Report
2026
May 7
Investor Presentation
2026
May 7
Investor Presentation
2026
Apr 14
Annual Report
2026
Apr 13
Proxy Solicitation & Information Statement
2026
Apr 13
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 17